Severe Influenza Treatment Guideline
|
|
Choi, Won Suk
(Department of Internal Medicine, Korea University College of Medicine)
Baek, Ji Hyeon (Department of Internal Medicine, Inha University School of Medicine) Seo, Yu Bin (Department of Internal Medicine, Hallym University College of Medicine) Kee, Sae Yoon (Department of Internal Medicine, Konkuk University School of Medicine) Jeong, Hye Won (Department of Internal Medicine, Chungbuk National University College of Medicine) Lee, Hee Young (Gachon University Gil Hospital Cancer Center, Gachon University Gil Medical Center) Eun, Byung Wook (Department of Pediatrics, Eulji University School of Medicine) Choo, Eun Ju (Department of Internal Medicine, Soonchunhyang University College of Medicine) Lee, Jacob (Department of Internal Medicine, Hallym University College of Medicine) Kim, Young Keun (Department of Internal Medicine, Yonsei University Wonju College of Medicine) Song, Joon Young (Department of Internal Medicine, Korea University College of Medicine) Wie, Seong-Heon (Department of Internal Medicine, The Catholic University of Korea College of Medicine) Lee, Jin Soo (Department of Internal Medicine, Inha University School of Medicine) Cheong, Hee Jin (Department of Internal Medicine, Korea University College of Medicine) Kim, Woo Joo (Department of Internal Medicine, Korea University College of Medicine) Transgovernmental Enterprise for Pandemic Influenza in Korea (Transgovernmental Enterprise for Pandemic Influenza in Korea) |
| 1 | Sadahiro T, Oda S, Nakamura M, Hirayama Y, Watanabe E, Tateishi Y, Shinozaki K. Trends in and perspectives on extracorporeal membrane oxygenation for severe adult respiratory failure. Gen Thorac Cardiovasc Surg 2012;60:192-201. DOI ScienceOn |
| 2 | Rodriguez A, Alvarez-Rocha L, Sirvent JM, et al. Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically III Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit. Med Intensiva 2012;36:103-137. DOI ScienceOn |
| 3 | Michaels AJ, Hill JG, Bliss D, et al. Pandemic flu and the sudden demand for ECMO resources: a mature trauma program can provide surge capacity in acute critical care crises. J Trauma Acute Care Surg 2013;74:1493-1497. DOI |
| 4 | Pappalardo F, Pieri M, Greco T, et al. Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A(H1N1) pneumonia: the ECMOnet score. Intensive Care Med 2013;39:275-281. DOI ScienceOn |
| 5 | Takeda S, Kotani T, Nakagawa S, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) severe respiratory failure in Japan. J Anesth 2012;26:650-657. DOI |
| 6 | Roncon-Albuquerque R Jr, Basilio C, Figueiredo P, et al. Portable miniaturized extracorporeal membrane oxygenation systems for H1N1-related severe acute respiratory distress syndrome: a case series. J Crit Care 2012;27:454-463. DOI ScienceOn |
| 7 | Sohn JW. Critical care paper review 2012. Tuberc Respir Dis (Seoul) 2012;73:1-10. DOI ScienceOn |
| 8 | Brink M, Hagberg L, Larsson A, Gedeborg R. Respiratory support during the influenza A(H1N1) pandemic flu in Sweden. Acta Anaesthesiol Scand 2012;56:976-986. DOI ScienceOn |
| 9 | Hou X, Guo L, Zhan Q, et al. Extracorporeal membrane oxygenation for critically ill patients with 2009 influenza A(H1N1)-related acute respiratory distress syndrome: preliminary experience from a single center. Artif Organs 2012;36:780-786. DOI ScienceOn |
| 10 | Shetty AK, Ross GA, Pranikoff T, et al. Oseltamivir-resistant 2009 H1N1 influenza pneumonia during therapy in a renal transplant recipient. Pediatr Transplant 2012;16:E153-157. DOI ScienceOn |
| 11 | Morgan CI, Hobson MJ, Seger B, Rice MA, Staat MA, Wheeler DS. 2009 pandemic influenza A(H1N1) in critically ill children in Cincinnati, Ohio. Pediatr Crit Care Med 2012;13:e140-144. DOI ScienceOn |
| 12 | Bonastre J, Suberviola B, Pozo JC, et al. Extracorporeal lung support in patients with severe respiratory failure secondary to the 2010-2011 winter seasonal outbreak of influenza A(H1N1) in Spain. Med Intensiva 2012;36:193-199. DOI ScienceOn |
| 13 | Lemaitre F, Luyt CE, Roullet-Renoleau F, et al. Impact of extracorporeal membrane oxygenation and continuous venovenous hemodiafiltration on the pharmacokinetics of oseltamivir carboxylate in critically ill patients with pandemic (H1N1) influenza. Ther Drug Monit 2012;34:171-175. DOI ScienceOn |
| 14 | Beurtheret S, Mastroianni C, Pozzi M, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome: single-centre experience with 1-year follow-up. Eur J Cardiothorac Surg 2012;41:691-695. DOI ScienceOn |
| 15 | Azevedo LC, Park M, Costa EL, et al. Extracorporeal membrane oxygenation in severe hypoxemia: time for reappraisal? J Bras Pneumol 2012;38:7-12. DOI |
| 16 | Lee KH, Yie K, Oh WS, Ryu SW, Chon SB, Lee SJ. Early extracorporeal membrane oxygenation in a patient with pandemic influenza (H1N1 2009) and acute respiratory distress syndrome. Infect Chemother 2010;42:122-126. |
| 17 | Li HL, Meng C, Zhu X, Guo LM, Li BS. The application of extracorporeal membrane oxygenation in critically ill patient. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2012;24:86-89. |
| 18 | Van Ierssel SH, Leven M, Jorens PG. Severe influenza A(H1N1)2009 infection: a single centre experience and review of the literature. Acta Clin Belg 2012;67:1-6. |
| 19 | Ji S, Lee OJ, Yang JH, et al. 2009 H1N1 influenza virus infection and necrotizing pneumonia treated with extracorporeal membrane oxygenation. Korean J Pediatr 2011;54:345-349. DOI ScienceOn |
| 20 | Dominguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009;302:1880-1887. DOI ScienceOn |
| 21 | Quispe-Laime AM, Bracco JD, Barberio PA, et al. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med 2010;36:33-41. DOI ScienceOn |
| 22 | Kil HR, Lee JH, Lee KY, Rhim JW, Youn YS, Kang JH. Early corticosteroid treatment for severe pneumonia caused by 2009 H1N1 influenza virus. Crit Care 2011;15:413. DOI |
| 23 | Sohn YR, Kim JH, Ma SH, Lee KY, Kang JH. Severe pneumonia caused by 2009 pandemic influenza A(H1N1) virus in children and corticosteroid treatment. Korean J Pediatr Infect Dis 2011;18:193-200. |
| 24 | Confalonieri M, D'Agaro P, Campello C. Corticosteroids do not cause harmful increase of viral load in severe H1N1 virus infection. Intensive Care Med 2010;36:1780-1781. DOI ScienceOn |
| 25 | Samejima T, Takayanagi N, Ishiguro T, Miyahara Y, Yanagisawa T, Sugita Y. Case of novel influenza A(H1N1) pneumonia with shrinkage of a pulmonary lesion. Nihon Kokyuki Gakkai Zasshi 2010;48:930-937. |
| 26 | Confalonieri M, Cifaldi R, Dreas L, Viviani M, Biolo M, Gabrielli M. Methylprednisolone infusion for life-threatening H1N1-virus infection. Ther Adv Respir Dis 2010;4:233-237. DOI ScienceOn |
| 27 | Ohtsuki N, Kimura S, Nezu A, Aihara Y. Effects of mild hypothermia and steroid pulse combination therapy on acute encephalopathy associated with influenza virus infection: report of two cases. No To Hattatsu 2000;32:318-322. |
| 28 | Hibino M, Akazawa K, Hikino K, Oe M. A case of acute respiratory distress syndrome associated with pandemic influenza A(H1N1) pneumonia which was aggravated by the cessation of corticosteroid therapy. Nihon Kokyuki Gakkai Zasshi 2011;49:955-963. |
| 29 | Ishiguro T, Takayanagi N, Kanauchi T, Hoshi T, Yanagisawa T, Sugita Y. Two patients with novel influenza A virus (H1N1) pneumonia treated with steroid therapy after an incorrect diagnosis of rapid progressive interstitial pneumonia due to the negative results of a rapid-antigen test. Nihon Kokyuki Gakkai Zasshi 2010;48:687-695. |
| 30 | Sakurai T, Kimura A, Tanaka Y, Hozumi I, Ogura S, Inuzuka T. Case of adult influenza type A virus-associated encephalopathy successfully treated with primary multidisciplinary treatments. Rinsho Shinkeigaku 2007;47:639-643. |
| 31 | Djibre M, Berkane N, Salengro A, et al. Non-invasive management of acute respiratory distress syndrome related to Influenza A(H1N1) virus pneumonia in a pregnant woman. Intensive Care Med 2010;36:373-374. DOI |
| 32 | Ando M, Miyazaki E, Hiroshige S, et al. Virus associated hemophagocytic syndrome accompanied by acute respiratory failure caused by influenza A (H3N2). Intern Med 2006;45:1183-1186. DOI |
| 33 | Munakata M, Kato R, Yokoyama H, et al. Combined therapy with hypothermia and anticytokine agents in influenza A encephalopathy. Brain Dev 2000;22:373-377. DOI ScienceOn |
| 34 | Athauda D, Andrews TC, Holmes PA, Howard RS. Multiphasic acute disseminated encephalomyelitis (ADEM) following influenza type A (swine specific H1N1). J Neurol 2012;259:775-778. DOI ScienceOn |
| 35 | Wang Y, Lu YY, Zheng J, Da W, Ping C, Da Dz. Treatment of critically ill influenza A H1N1 patients in plateau region. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2010;22:153-155. |
| 36 | Kawashima H, Togashi T, Yamanaka G, et al. Efficacy of plasma exchange and methylprednisolone pulse therapy on influenza-associated encephalopathy. J Infect 2005;51:E53-56. DOI ScienceOn |
| 37 | Roberts C, Nirmalan M, O'Shea S. Steroid-sensitive post-viral inflammatory pneumonitis (PVIP). Am J Respir Crit Care Med 2010;182:1089-1090. |
| 38 | Martin-Loeches I, Lisboa T, Rhodes A, et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med 2011;37:272-283. DOI ScienceOn |
| 39 | Mady A, Ramadan OS, Yousef A, Mandourah Y, Amr AA, Kherallah M. Clinical experience with severe 2009 H1N1 influenza in the intensive care unit at King Saud Medical City, Saudi Arabia. J Infect Public Health 2012;5:52-56. DOI ScienceOn |
| 40 | Linko R, Pettila V, Ruokonen E, et al. Corticosteroid therapy in intensive care unit patients with PCR-confirmed influenza A(H1N1) infection in Finland. Acta Anaesthesiol Scand 2011;55:971-979. DOI |
| 41 | Han K, Ma H, An X, et al. Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection. Clin Infect Dis 2011;53:326-333. DOI ScienceOn |
| 42 | Maravi-Poma E, Martin-Loeches I, Regidor E, et al. Severe 2009 A/H1N1v influenza in pregnant women in Spain. Crit Care Med 2011;39:945-951. DOI ScienceOn |
| 43 | Diaz E, Martin-Loeches I, Canadell L, et al. Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza. J Infect 2012;64:311-318. DOI ScienceOn |
| 44 | Kawashima H, Morichi S, Okumara A, Nakagawa S, Morishima T; Collaborating Study Group on Influenza-Associated Encephalopathy in Japan. Treatment of pandemic influenza A(H1N1) 2009-associated encephalopathy in children. Scand J Infect Dis 2012;44:941-947. DOI ScienceOn |
| 45 | Brun-Buisson C, Richard JC, Mercat A, Thiebaut AC, Brochard L; REVA-SRLF A/H1N1v 2009 Registry Group. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 2011;183:1200-1206. DOI ScienceOn |
| 46 | Kim SH, Hong SB, Yun SC, et al. Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med 2011;183:1207-1214. DOI ScienceOn |
| 47 | Chong JL, Sapari S, Kuan YC. A case of acute respiratory distress syndrome associated with novel H1N1 treated with intravenous immunoglobulin G. J Microbiol Immunol Infect 2011;44:319-322. DOI ScienceOn |
| 48 | Gordon CL, Langan K, Charles PG, et al. Pooled human immunoglobulin therapy in critically Ill patients with pandemic 2009 influenza A(H1N1) pneumonitis and immunoglobulin G2 subclass (IgG2) deficiency. Clin Infect Dis 2011;52:422-426. |
| 49 | Zhang R, Jin L, Jin M, et al. Clinical analysis of children with lymphoma complicated with severe pneumonia due to novel influenza A(H1N1) virus infection. Zhonghua Er Ke Za Zhi 2010;48:610-613. |
| 50 | Iwanaga N, Nakamura S, Tanaka A, et al. An adult case of influenza-associated encephalitis successfully treated with high dose intravenous immunoglobulins. Kansenshogaku Zasshi 2012;86:295-299. DOI |
| 51 | Frost FJ, Petersen H, Tollestrup K, Skipper B. Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest 2007;131:1006-1012. DOI ScienceOn |
| 52 | Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG. Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis 2007;7:358-368. DOI ScienceOn |
| 53 | Vandermeer ML, Thomas AR, Kamimoto L, et al. Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study. J Infect Dis 2012;205:13-19. DOI ScienceOn |
| 54 | Kwong JC, Li P, Redelmeier DA. Influenza morbidity and mortality in elderly patients receiving statins: a cohort study. PLoS One 2009;4:e8087. DOI ScienceOn |
| 55 | Brett SJ, Myles P, Lim WS, et al. Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease. PLoS One 2011;6:e18120. DOI ScienceOn |
| 56 | Carrillo-Esper R, Sosa-Garcia JO, Arch-Tirado E. Experience in the management of the severe form of human influenza A H1N1 pneumonia in an intensive care unit. Cir Cir 2011;79:409-416. |
| 57 | Viasus D, Pano-Pardo JR, Cordero E, et al. Effect of immunomodulatory therapies in patients with pandemic influenza A(H1N1) 2009 complicated by pneumonia. J Infect 2011;62:193-199. DOI ScienceOn |
| 58 | Patel P, Nandwani V, Vanchiere J, Conrad SA, Scott LK. Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A: an associated respiratory failure and hemodynamic shock. Pediatr Crit Care Med 2011;12:e87-89. DOI |
| 59 | Choi WS, Lee J, Lee HY, et al. Clinical practice guideline for antiviral treatment and chemoprophylaxis of seasonal influenza. Infect Chemother 2012;44:233-249. DOI |
| 60 | Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial: US Oral Neuraminidase Study Group. JAMA 2000;283:1016-1024. DOI ScienceOn |
| 61 | Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial: Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000;355:1845-1850. DOI ScienceOn |
| 62 | World Health Organization. WHO guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses [Internet]. Geneva (CH): World Health Organization, c2013 [cited 2013 Oct 2]. Available from: http://www.who.int/csr/resources/publications/swineflu/h1n1_use_antivirals_20090820/en. |
| 63 | Hayden FG, Treanor JJ, Fritz RS, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999;282:1240-1246. DOI ScienceOn |
| 64 | Kohno S, Kida H, Mizuguchi M, et al. Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients. Antimicrob Agents Chemother 2011;55:2803-2812. DOI ScienceOn |
| 65 | Yang SG, Cao B, Liang LR, et al. Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus. PLoS One 2012;7:e29652. DOI |
| 66 | South East Asia Infectious Disease Clinical Research Network. Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial. BMJ 2013;346:f3039. DOI |
| 67 | Lee N, Hui DS, Zuo Z, et al. A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections. Clin Infect Dis 2013;57:1511-1519. DOI ScienceOn |
| 68 | Kim AR, Kim ES, Pai KS, Park JE. A case of high dose oseltamivir treatment in an influenza A(H1N1) infected patient with severe graft versus host disease. Clin Pediatr Hematol Oncol 2011;18:58-61. |
| 69 | Kang SJ, Park KH, Kee SJ, et al. Virological clearance rate of high-dose oseltamivir or triple-combination antiviral therapy in complicated 2009 pandemic influenza A(H1N1) infection. Jpn J Infect Dis 2013;66:425-427. DOI |
| 70 | Duval X, van der Werf S, Blanchon T, et al. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med 2010;7:e1000362. DOI ScienceOn |
| 71 | Leekha S, Zitterkopf NL, Espy MJ, Smith TF, Thompson RL, Sampathkumar P. Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol 2007;28:1071-1076. DOI ScienceOn |
| 72 | Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60:1-24. |
| 73 | Escuret V, Cornu C, Boutitie F, et al. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections. Antiviral Res 2012;96:130-137. DOI ScienceOn |
| 74 | Smee DF, Hurst BL, Wong MH, Bailey KW, Morrey JD. Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice. Antimicrob Agents Chemother 2009;53:2120-2128. DOI ScienceOn |
| 75 | Nguyen JT, Hoopes JD, Smee DF, et al. Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrob Agents Chemother 2009;53:4115-4126. DOI ScienceOn |
| 76 | Kim WY, Suh GY, Huh JW, et al. Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation. Antimicrob Agents Chemother 2011;55:5703-5709. DOI |
| 77 | Fraaij PL, van der Vries E, Beersma MF, et al. Evaluation of the antiviral response to zanamivir administered intravenously for treatment of critically ill patients with pandemic influenza A(H1N1) infection. J Infect Dis 2011;204:777-782. DOI ScienceOn |
| 78 | Spurling GK, Del Mar CB, Dooley L, Foxlee R, Farley R. Delayed antibiotics for respiratory infections. Cochrane Database Syst Rev 2013;4:CD004417. |
| 79 | Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat. Cochrane Database Syst Rev 2004;(2):CD000023. |
| 80 | Petersen E, Keld DB, Ellermann-Eriksen S, et al. Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A(H1N1)v. Scand J Infect Dis 2011;43:495-503. DOI ScienceOn |
| 81 | Smucny J, Fahey T, Becker L, Glazier R. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2004;(4):CD000245. |
| 82 | Morciano C, Vitale A, De Masi S, et al. Italian evidence-based guidelines for the management of influenza-like syndrome in adults and children. Ann Ist Super Sanita 2009;45:185-192. |
| 83 | Centers for Disease Control and Prevention (CDC). Surveillance for pediatric deaths associated with 2009 pandemic influenza A(H1N1) virus infection-United States, April-August 2009. MMWR Morb Mortal Wkly Rep 2009;58:941-947. |
| 84 | Wright PF, Kirkland KB, Modlin JF. When to consider the use of antibiotics in the treatment of 2009 H1N1 influenza-associated pneumonia. N Engl J Med 2009;361:e112. DOI |
| 85 | Song JH, Jung KS, Kang MW, et al. Treatment guidelines for community-acquired pneumonia in Korea: an evidence-based approach to appropriate antimicrobial therapy. Infect Chemother 2009;41:133-153. DOI |
| 86 | The Korean Otologic Society. Korean Clinical Practice Guideline: Otitis Media in Children 2010 [Internet]. Seoul: Korean Otologic Society, c2010 [cited 2013 Oct 2]. Available from: http://www.guideline.or.kr. |
| 87 | Paden ML, Conrad SA, Rycus PT, Thiagarajan RR; ELSO Registry. Extracorporeal life support organization registry report 2012. ASAIO J 2013;59:202-210. DOI ScienceOn |
| 88 | Zangrillo A, Biondi-Zoccai G, Landoni G, et al. Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO. Crit Care 2013;17:R30. DOI |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
